Finance

Beta
Lists
PALI:NASDAQ
Palisade Bio Inc
$1.68
-3.74%
(-0.065) 1D
Jun 9, 1:17:53 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PALI...
Open
$1.75
High
$1.76
Low
$1.64
Mkt. cap
289.01M
Avg. vol.
2.83M
Volume
1.09M
52-wk high
$2.86
52-wk low
$0.53
EPS
-$1.17
Beta
1.52
Shares outstanding
173.58M
No. of employees
14
Open
$1.75
High
$1.76
Low
$1.64
Mkt. cap
289.01M
Avg. vol.
2.83M
Volume
1.09M
52-wk high
$2.86
52-wk low
$0.53
EPS
-$1.17
Beta
1.52
Shares outstanding
173.58M
No. of employees
14
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to PALI in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PALI in the last 3 months.
Highest
Current $1.68
$25.00 (+1,392.54%)
Average
$10.14 (+505.37%)
Lowest
$5.00 (+198.51%)
News stories
From sources across the web
About Palisade Bio Inc
CEO-
Employees14
Founded2005
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websitepalisadebio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.68M
1.39M
6.17M
6.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.17M
1.53M
3.81M
4.35M
Operating expense
2.84M
2.92M
9.98M
10.75M
Total operating expenses
2.84M
2.92M
9.98M
10.75M
Operating income
-2.84M
-2.92M
-9.98M
-10.75M
Other non operating income
61.00K
59.00K
1.08M
1.15M
EBT including unusual items
-2.78M
-2.87M
-8.90M
-9.60M
EBT excluding unusual items
-2.78M
-2.87M
-8.90M
-9.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.78M
-2.87M
-8.90M
-9.60M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.38
-
-0.05
Interest and investment income
-
-
-
-
Interest expense
-2.00K
-5.00K
-2.00K
-1.00K
Net interest expenses
-2.00K
-5.00K
-2.00K
-1.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.84M
-2.92M
-9.98M
-10.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer